{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:13:15Z","timestamp":1792624395997,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.gastrohep.2025.502346","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T19:45:27Z","timestamp":1737229527000},"page":"502346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Dongyuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2025.502346_bib0420","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"De Valle","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0425","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaut.2013.07.005","article-title":"Geoepidemiology of primary sclerosing cholangitis: a critical review","volume":"46","author":"Tanaka","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0430","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.gastro.2019.11.294","article-title":"Differences in gut microbiota in patients with vs without inflammatory bowel diseases: a systematic review","volume":"158","author":"Pittayanon","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0440","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0445","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0450","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5217\/ir.2022.00087","article-title":"Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India","volume":"21","author":"Singh","year":"2023","journal-title":"Intest Res"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0455","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","article-title":"Primary sclerosing cholangitis in the Swiss inflammatory bowel disease cohort study: prevalence, risk factors, and long-term follow-up","volume":"29","author":"Fraga","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0460","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0465","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0470","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-019-0967-3","article-title":"Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study","volume":"19","author":"Fousekis","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0475","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ueg2.12204","article-title":"Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"UEG J"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0480","doi-asserted-by":"crossref","first-page":"1225616","DOI":"10.3389\/fmed.2023.1225616","article-title":"Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population","volume":"10","author":"Abu-Freha","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0485","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0490","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0495","first-page":"229","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975\u20131981","volume":"63","author":"Tobias","year":"1983","journal-title":"S Afr Med J"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0500","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365529108996489","article-title":"Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease","volume":"26","author":"Wewer","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0505","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0510","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/00365529709025107","article-title":"Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease","volume":"32","author":"Rasmussen","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0515","doi-asserted-by":"crossref","unstructured":"Parlak E, Kosar Y, Ulker A, Dagli U, Alkim C, Sahin B. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey. J Clin Gastroenterol. 2001;33:299-301. doi: 10.1097\/00004836-200110000-00008.","DOI":"10.1097\/00004836-200110000-00008"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0520","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"WJG"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0525","doi-asserted-by":"crossref","unstructured":"Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, D\u00edaz-Rubio M. Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis]. Med Clin (Barc). 2005;125:297-300. doi: 10.1157\/13078423.","DOI":"10.1157\/13078423"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0530","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.meg.0000243883.47938.aa","article-title":"Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations","volume":"19","author":"Barreiro-de Acosta","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0535","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ibd.20529","article-title":"Prevalence of penetrating disease and extraintestinal manifestations of Crohn\u02bcs disease detected with CT enterography","volume":"14","author":"Bruining","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0540","first-page":"454","article-title":"Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007","volume":"12","author":"Vahedi","year":"2009","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0545","doi-asserted-by":"crossref","first-page":"12269","DOI":"10.3748\/wjg.v20.i34.12269","article-title":"Smoking increases the risk of extraintestinal manifestations in Crohn's disease","volume":"20","author":"Ott","year":"2014","journal-title":"WJG"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0550","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000363228","article-title":"Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking","volume":"90","author":"Roberts","year":"2014","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0555","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.3748\/wjg.v20.i46.17463","article-title":"Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients","volume":"20","author":"Zippi","year":"2014","journal-title":"WJG"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0560","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","article-title":"Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort","volume":"50","author":"Isene","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0565","first-page":"200","article-title":"Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in North-East of Iran","volume":"8","author":"Khosravi Khorashad","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench."},{"key":"10.1016\/j.gastrohep.2025.502346_bib0570","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12664-015-0538-7","article-title":"Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype","volume":"34","author":"Singh","year":"2015","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0575","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris","year":"2016","journal-title":"ECCOJC"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0580","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"WJG"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0585","doi-asserted-by":"crossref","first-page":"e0200363","DOI":"10.1371\/journal.pone.0200363","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13","author":"Yang","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0590","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0595","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/s10620-020-06424-x","article-title":"Extraintestinal manifestations in patients with inflammatory bowel disease: study based on the ENEIDA registry","volume":"66","author":"Algaba","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0600","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gastrohep.2020.07.012","article-title":"Caracterizaci\u00f3n y prevalencia de manifestaciones extraintestinales en una cohorte de pacientes con enfermedad inflamatoria intestinal en Medell\u00edn (Colombia)","volume":"44","author":"Juliao-Ba\u00f1os","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0605","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dld.2020.06.046","article-title":"Extraintestinal manifestation of inflammatory bowel disease in asian patients: a multinational study","volume":"53","author":"Park","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0610","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Duperly R, L\u00f3pez Panqueva RdP, Londo\u00f1o Schimmer EE, Rey Rubiano AMM, Padron Mercado J, Medell\u00edn Abueta AY, et al. Caracter\u00edsticas de la enfermedad inflamatoria intestinal con respecto a otros centros nacionales de Colombia. Rev Colomb Gastroenterol. 2022;37:48\u201357. https:\/\/doi.org\/10.22516\/25007440.752.","DOI":"10.22516\/25007440.752"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0615","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.3748\/wjg.v29.i29.4481","article-title":"Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: a literature review","volume":"29","author":"Wang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0620","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000529816","article-title":"Clinical features focusing on extraintestinal manifestations in japanese patients with inflammatory bowel diseases: far east 1000","volume":"104","author":"Ohta","year":"2023","journal-title":"Digestion"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0625","article-title":"Incidence and risk factors for neoplasia in inflammatory bowel disease","author":"Garcia","year":"2023","journal-title":"Asia-Pac J Clncl Oncology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0630","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0635","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0640","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0645","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0650","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/MEG.0b013e328331c2b7","article-title":"Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study","volume":"22","author":"Garioud","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0655","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0660","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0665","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0670","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0675","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0680","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/00365521.2012.682090","article-title":"Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis","volume":"47","author":"Srivastava","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0685","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis: Boonstra et al.","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0690","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","article-title":"Prognosis of primary sclerosing cholangitis in Israel is independent of coexisting inflammatory bowel disease","volume":"9","author":"Yanai","year":"2015","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0695","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0700","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajg.2015.09.004","article-title":"Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran","volume":"17","author":"Hadizadeh","year":"2016","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0705","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MIB.0000000000000690","article-title":"Impact of concurrent non-IBD immunological diseases on the outcome of primary sclerosing cholangitis","volume":"22","author":"Jegadeesan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0710","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.cgh.2016.07.032","article-title":"No evidence that azathioprine increases risk of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"14","author":"Zenouzi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0715","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00365521.2016.1250281","article-title":"Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma","volume":"52","author":"Boyd","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0720","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jgh.13774","article-title":"Variations in primary sclerosing cholangitis across the age spectrum","volume":"32","author":"Eaton","year":"2017","journal-title":"J Gastrol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0725","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.13328","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort","volume":"37","author":"Liu","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0730","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0735","doi-asserted-by":"crossref","first-page":"e0202942","DOI":"10.1371\/journal.pone.0202942","article-title":"PNPLA3 p.I148 M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: a prospective analysis of 178 patients with PSC","volume":"13","author":"Kruk","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0740","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0745","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.dld.2021.05.009","article-title":"Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis","volume":"53","author":"Koskensalo","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7746401","article-title":"Clinical features and outcomes of primary sclerosing cholangitis in the highly admixed Brazilian population","volume":"2021","author":"Nardelli","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0755","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","article-title":"Increased risk of cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Lundberg B\u00e5ve","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0760","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.gastrohep.2021.03.017","article-title":"Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: experience of a transplant center in the Mediterranean Basin","volume":"45","author":"M\u00ednguez Sabater","year":"2022","journal-title":"Gastroenterol Hepatol (Engl Ed)"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0765","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/08998280.2023.2254196","article-title":"Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes","volume":"36","author":"Elfert","year":"2023","journal-title":"Baylor Univ Med Center Proc"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0770","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0775","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/00365529709000186","article-title":"Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease","volume":"32","author":"Heikius","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0780","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jgh.12947","article-title":"Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (I Nflammatory B Owel D Isease C Ohort of the U Ppsala R Egion)","volume":"30","author":"R\u00f6nnblom","year":"2015","journal-title":"J Gastrol Hepatol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0785","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0790","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0795","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0800","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/MCG.0000000000001282","article-title":"IBD in India: similar phenotype but different demographics than the west","volume":"54","author":"Banerjee","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0805","article-title":"Anti-integrin Av\u03b26 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study","author":"Yasuda","year":"2024","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0810","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0820","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0825","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/eva.13167","article-title":"Why women have more autoimmune diseases than men: an evolutionary perspective","volume":"14","author":"Kronzer","year":"2021","journal-title":"Evol Appl"},{"key":"10.1016\/j.gastrohep.2025.502346_bib0830","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ecco-jcc\/jjad157","article-title":"Prevalence of hepatobiliary manifestations in inflammatory bowel disease: a GRADE assessed systematic review and meta-analysis of more than 1.7 million patients","volume":"18","author":"Beheshti Maal","year":"2024","journal-title":"J Crohns Colitis"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570525000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:49:32Z","timestamp":1760082572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570525000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0210570525000111"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502346","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and bidirectional association between primary sclerosing cholangitis and Crohn's disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2025.502346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502346"}}